blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3320901

EP3320901 - DIMETHYLAMINOMICHELIOLIDE FOR USE IN THE TREATMENT OF PULMONARY FIBROSIS [Right-click to bookmark this link]
Former [2018/20]APPLICATION OF DIMETHYLAMINO MICHELIOLIDE
[2019/43]
StatusNo opposition filed within time limit
Status updated on  08.01.2021
Database last updated on 02.07.2024
FormerThe patent has been granted
Status updated on  31.01.2020
FormerGrant of patent is intended
Status updated on  29.10.2019
FormerExamination is in progress
Status updated on  14.06.2019
FormerRequest for examination was made
Status updated on  13.04.2018
FormerThe international publication has been made
Status updated on  04.08.2017
Most recent event   Tooltip27.04.2024Lapse of the patent in a contracting state
New state(s): MK		published on 29.05.2024  [2024/22]
Applicant(s)For all designated states
Accendatech
Room 927, Building C
5 Lanyuan St.
Huayuan Industry Development Area
Tianjin 300384 / CN
For all designated states
Tianjin International Joint Academy of Biotechnology & Medicine
220 Dongting Road, TEDA
Tianjin 300457 / CN
[2020/04]
Former [2018/20]For all designated states
Tianjin International Joint Academy of Biotechnology & Medicine
220 Dongting Road, TEDA
Tianjin 300457 / CN
For all designated states
Accendatech
Room 927, Building C
5 Lanyuan St.
Huayuan Industry Development Area
Tianjin 300384 / CN
Inventor(s)01 / SUN, Tao
220 Dongting Road
TEDA
Tianjin 300457 / CN
02 / CHEN, Yue
Room 927 Building C
5 Lanyuan St.
Huayuan Industry Development Area
Tianjin 300384 / CN
03 / YANG, Cheng
220 Dongting Road
TEDA
Tianjin 300457 / CN
04 / ZHOU, Honggang
220 Dongting Road
TEDA
Tianjin 300457 / CN
05 / LIU, Huijuan
220 Dongting Road
TEDA
Tianjin 300457 / CN
06 / LIU, Yanrong
220 Dongting Road
TEDA
Tianjin 300457 / CN
07 / WANG, Jing
220 Dongting Road
TEDA
Tianjin 300457 / CN
08 / ZHANG, Chengyu
220 Dongting Road
TEDA
Tianjin 300457 / CN
09 / ZHANG, Qiang
220 Dongting Road
TEDA
Tianjin 300457 / CN
10 / ZHANG, Xiangming
220 Dongting Road
TEDA
Tianjin 300457 / CN
11 / QIN, Yuan
220 Dongting Road
TEDA
Tianjin 300457 / CN
12 / JING, Xueshuang
220 Dongting Road
TEDA
Tianjin 300457 / CN
 [2018/20]
Representative(s)Sun, Yiming
HUASUN Patent- und Rechtsanwälte
Friedrichstraße 33
80801 München / DE
[2018/20]
Application number, filing date16887050.928.01.2016
[2018/20]
WO2016CN72445
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017128163
Date:03.08.2017
Language:ZH
[2017/31]
Type: A1 Application with search report 
No.:EP3320901
Date:16.05.2018
Language:EN
[2018/20]
Type: B1 Patent specification 
No.:EP3320901
Date:04.03.2020
Language:EN
[2020/10]
Search report(s)International search report - published on:CN03.08.2017
(Supplementary) European search report - dispatched on:EP15.10.2018
ClassificationIPC:A61K31/365, A61P11/00, A61P43/00, A61K9/00
[2018/46]
CPC:
A61K31/365 (EP,US); A61K9/0019 (US); A61K9/0053 (US);
A61K9/0073 (US); A61P11/00 (EP,US)
Former IPC [2018/20]A61K31/365, A61P1/16
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/20]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:DIMETHYLAMINOMICHELIOLID ZUR BEHANDLUNG VON LUNGENFIBROSE[2019/43]
English:DIMETHYLAMINOMICHELIOLIDE FOR USE IN THE TREATMENT OF PULMONARY FIBROSIS[2019/43]
French:DIMÉTHYLAMINOMICHELIOLIDE DESTINÉ AU TRAITEMENT DE LA FIBROSE PULMONAIRE[2019/43]
Former [2018/20]ANWENDUNG VON DIMETHYLAMINO-MICHELIOLID
Former [2018/20]APPLICATION OF DIMETHYLAMINO MICHELIOLIDE
Former [2018/20]UTILISATION DE DIMÉTHYLAMINO MICHELIOLIDE
Entry into regional phase09.02.2018Translation filed 
09.02.2018National basic fee paid 
09.02.2018Search fee paid 
09.02.2018Designation fee(s) paid 
09.02.2018Examination fee paid 
Examination procedure09.02.2018Examination requested  [2018/20]
09.02.2018Date on which the examining division has become responsible
30.04.2019Amendment by applicant (claims and/or description)
18.06.2019Despatch of a communication from the examining division (Time limit: M04)
10.09.2019Reply to a communication from the examining division
30.10.2019Communication of intention to grant the patent
23.01.2020Fee for grant paid
23.01.2020Fee for publishing/printing paid
23.01.2020Receipt of the translation of the claim(s)
Opposition(s)07.12.2020No opposition filed within time limit [2021/06]
Fees paidRenewal fee
09.02.2018Renewal fee patent year 03
23.11.2018Renewal fee patent year 04
13.12.2019Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY04.03.2020
CZ04.03.2020
EE04.03.2020
LT04.03.2020
LV04.03.2020
MC04.03.2020
MK04.03.2020
RO04.03.2020
RS04.03.2020
SI04.03.2020
SK04.03.2020
SM04.03.2020
BG04.06.2020
GR05.06.2020
IS04.07.2020
[2024/22]
Former [2023/30]CY04.03.2020
CZ04.03.2020
EE04.03.2020
LT04.03.2020
LV04.03.2020
MC04.03.2020
RO04.03.2020
RS04.03.2020
SI04.03.2020
SK04.03.2020
SM04.03.2020
BG04.06.2020
GR05.06.2020
IS04.07.2020
Former [2021/40]CZ04.03.2020
EE04.03.2020
LT04.03.2020
LV04.03.2020
MC04.03.2020
RO04.03.2020
RS04.03.2020
SI04.03.2020
SK04.03.2020
SM04.03.2020
BG04.06.2020
GR05.06.2020
IS04.07.2020
Former [2021/13]CZ04.03.2020
EE04.03.2020
LT04.03.2020
LV04.03.2020
RO04.03.2020
RS04.03.2020
SI04.03.2020
SK04.03.2020
SM04.03.2020
BG04.06.2020
GR05.06.2020
IS04.07.2020
Former [2020/50]CZ04.03.2020
EE04.03.2020
LT04.03.2020
LV04.03.2020
RO04.03.2020
RS04.03.2020
SK04.03.2020
SM04.03.2020
BG04.06.2020
GR05.06.2020
IS04.07.2020
Former [2020/49]CZ04.03.2020
LT04.03.2020
LV04.03.2020
RO04.03.2020
RS04.03.2020
SK04.03.2020
SM04.03.2020
BG04.06.2020
GR05.06.2020
IS04.07.2020
Former [2020/48]LT04.03.2020
LV04.03.2020
RO04.03.2020
RS04.03.2020
SM04.03.2020
BG04.06.2020
GR05.06.2020
IS04.07.2020
Former [2020/47]LT04.03.2020
LV04.03.2020
RS04.03.2020
BG04.06.2020
GR05.06.2020
IS04.07.2020
Former [2020/46]LV04.03.2020
RS04.03.2020
BG04.06.2020
GR05.06.2020
IS04.07.2020
Former [2020/39]LV04.03.2020
RS04.03.2020
BG04.06.2020
GR05.06.2020
Former [2020/38]LV04.03.2020
RS04.03.2020
GR05.06.2020
Former [2020/37]LV04.03.2020
RS04.03.2020
Documents cited:Search[A]EP2562172  (ACCENDATECH [CN], et al) [A] 1-5 * abstract ** claims 1-10 *;
 [A]  - YINGHONG AN ET AL, "Micheliolide Derivative DMAMCL Inhibits Glioma Cell Growth In Vitro and In Vivo", PLOS ONE, (20150206), vol. 10, no. 2, doi:10.1371/journal.pone.0116202, page e0116202, XP055512656 [A] 1-5 * abstract *

DOI:   http://dx.doi.org/10.1371/journal.pone.0116202
International search[A]CN104876899  (ACCENDATECH CO LTD) [A] 1-5* the whole document *;
 [E]CN105520933  (TIANJIN INT JOINT ACAD OF BIOMEDICINE, et al) [E] 1-5 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.